Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1423824/000119312518306370/d634300d8k.htm
October 2019
September 2019
August 2019
May 2019
May 2019
May 2019
April 2019
March 2019
March 2019
March 2019
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1423824/000119312518306370/d634300d8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alder Biopharmaceuticals Inc.
Alder Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: ALDREvents:
CIK: 1423824
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-306370
Submitted to the SEC: Wed Oct 24 2018 4:05:35 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Tuesday, October 23, 2018
Industry: Pharmaceutical Preparations